Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TSNAXIP1 |
| Upstream (Parents) |
|---|
| (<<) CCDC102B → TSNAXIP1 |
| (<<) APOLD1 → TSNAXIP1 |
| (<<) COL4A1 → TSNAXIP1 |
| (<<) ACTG2 → TSNAXIP1 |
| (<<) LACTB2 → TSNAXIP1 |
| (<<) DRD5 → TSNAXIP1 |
| Downstream (Children) |
|---|
| TSNAXIP1 → SSX3 (>>) |
| TSNAXIP1 → DBC1 (>>) |
| TSNAXIP1 → CALCB (>>) |
| TSNAXIP1 → MS4A5 (>>) |
| TSNAXIP1 → BPNT1 (>>) |
| TSNAXIP1 → JMJD6 (>>) |
| TSNAXIP1 → USP46 (>>) |
| TSNAXIP1 → P2RX1 (>>) |
| TSNAXIP1 → NPY5R (>>) |
| TSNAXIP1 → KCNH4 (>>) |
| TSNAXIP1 → HCFC1 (>>) |
| TSNAXIP1 → RFPL2 (>>) |
| TSNAXIP1 → TSHB (>>) |
| TSNAXIP1 → DRD5 (>>) |
| TSNAXIP1 → NEUROD4 (>>) |
